Published in J Clin Oncol on January 20, 2008
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol (2012) 1.74
Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer (2009) 1.69
Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst (2012) 1.64
Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen (2008) 1.48
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol (2013) 1.13
Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control (2013) 1.11
Secondary malignancies across the age spectrum. Semin Radiat Oncol (2010) 1.04
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol (2010) 0.96
Nicotine and lung cancer. J Carcinog (2013) 0.92
Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy. Breast Cancer Res (2011) 0.89
Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data. Cancer Epidemiol (2013) 0.89
Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol (2012) 0.89
Current knowledge and future research directions in treatment-related second primary malignancies. EJC Suppl (2014) 0.85
Second malignancies following conventional or combined ²⁵²Cf neutron brachytherapy with external beam radiotherapy for breast cancer. J Radiat Res (2013) 0.83
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer (2012) 0.82
Pathological confirmation of primary lung cancer following breast cancer. Lung Cancer (2009) 0.82
Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia. Support Care Cancer (2011) 0.77
Breast cancer survival among young women: a review of the role of modifiable lifestyle factors. Cancer Causes Control (2016) 0.77
Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.77
Lung adenocarcinoma in a patient with plasmacytoma. Case Rep Hematol (2013) 0.75
Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual? J Clin Oncol (2008) 0.75
[Second primary cancers after radiotherapy in breast cancer patients]. Strahlenther Onkol (2013) 0.75
Second primary lung carcinoma in patients with first primary breast carcinoma: two case reports and review of the literature. Cases J (2009) 0.75
Is there a role for IGF-1 in the development of second primary cancers? Cancer Med (2016) 0.75
Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? Clin Lung Cancer (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 5.62
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol (2007) 3.92
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med (2013) 3.41
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97
Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev (2002) 2.83
Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging? Gastrointest Endosc (2013) 2.80
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59
Use of the Internet by women with breast cancer. J Med Internet Res (2003) 2.46
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36
Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol (2006) 2.26
Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst (2007) 2.24
Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer (2013) 2.14
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11
Epidemiology of upper gastrointestinal malignancies. Semin Oncol (2004) 2.10
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Electric blanket use and breast cancer on Long Island. Epidemiology (2003) 2.06
Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05
Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04
Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol (2005) 2.03
The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg (2013) 2.01
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00
Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98
Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev (2004) 1.96
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Lifetime alcohol intake and breast cancer risk. Ann Epidemiol (2005) 1.85
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. Eur Urol (2006) 1.76
Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76
Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.73
Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol (2013) 1.72
Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology (2008) 1.71
Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol (2010) 1.71
Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer (2009) 1.70
Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support. Prev Med (2005) 1.70
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68
Internet use and social support in women with breast cancer. Health Psychol (2002) 1.67
Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol (2011) 1.66
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat (2009) 1.66
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J (2012) 1.64
Lung cancer risk in white and black Americans. Ann Epidemiol (2003) 1.63
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61
Diabetes mellitus and the risk of prostate cancer. Cancer Invest (2002) 1.60
Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58
Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg (2013) 1.57
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57
The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. BJU Int (2009) 1.55
Health belief model factors in mammography screening: testing for interactions among subpopulations of Caribbean women. Ethn Dis (2005) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol (2011) 1.54
Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity? Dig Dis Sci (2013) 1.53
Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology (2016) 1.52
Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomarkers Prev (2006) 1.52